Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03571568
Title A Study of BI-1206 in Combination With Rituximab in Subjects With Indolent B-Cell Non-Hodgkin Lymphoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors BioInvent International AB

marginal zone B-cell lymphoma

non-Hodgkin lymphoma

follicular lymphoma

mantle cell lymphoma


BI-1206 + Rituximab

Age Groups: senior | adult
Covered Countries USA | ESP

No variant requirements are available.